127 related articles for article (PubMed ID: 36191998)
1. Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherin.
Dembélé P; Garnier O; Martin DK; Vilgrain I
Anticancer Res; 2022 Oct; 42(10):4689-4700. PubMed ID: 36191998
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues.
Lambeng N; Wallez Y; Rampon C; Cand F; Christé G; Gulino-Debrac D; Vilgrain I; Huber P
Circ Res; 2005 Feb; 96(3):384-91. PubMed ID: 15662029
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma.
Polena H; Creuzet J; Dufies M; Sidibé A; Khalil-Mgharbel A; Salomon A; Deroux A; Quesada JL; Roelants C; Filhol O; Cochet C; Blanc E; Ferlay-Segura C; Borchiellini D; Ferrero JM; Escudier B; Négrier S; Pages G; Vilgrain I
Br J Cancer; 2018 May; 118(9):1179-1188. PubMed ID: 29563634
[TBL] [Abstract][Full Text] [Related]
4. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
5. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
Tang FY; Nguyen N; Meydani M
Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064
[TBL] [Abstract][Full Text] [Related]
6. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
7. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ
Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability.
Nwariaku FE; Liu Z; Zhu X; Turnage RH; Sarosi GA; Terada LS
Surgery; 2002 Aug; 132(2):180-5. PubMed ID: 12219009
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.
Esser S; Lampugnani MG; Corada M; Dejana E; Risau W
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1853-65. PubMed ID: 9625748
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis: the VE-cadherin switch.
Wallez Y; Vilgrain I; Huber P
Trends Cardiovasc Med; 2006 Feb; 16(2):55-9. PubMed ID: 16473763
[TBL] [Abstract][Full Text] [Related]
12. ECSM2, an endothelial specific VE-cadherin binding protein, has a tyrosine phosphorylation site essential to cell migration.
Xiang H; Ma J; Shen P; Wang Y; Huang H; Shi C
Gene; 2018 Jul; 662():131-138. PubMed ID: 29653231
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
Hatanaka K; Lanahan AA; Murakami M; Simons M
PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427
[TBL] [Abstract][Full Text] [Related]
15. Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation.
van Buul JD; Anthony EC; Fernandez-Borja M; Burridge K; Hordijk PL
J Biol Chem; 2005 Jun; 280(22):21129-36. PubMed ID: 15778498
[TBL] [Abstract][Full Text] [Related]
16. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of VE-cadherin and claudin-5 and increased phosphorylation of VE-cadherin in vascular endothelium in nasal polyps.
Yukitatsu Y; Hata M; Yamanegi K; Yamada N; Ohyama H; Nakasho K; Kojima Y; Oka H; Tsuzuki K; Sakagami M; Terada N
Cell Tissue Res; 2013 Jun; 352(3):647-57. PubMed ID: 23474739
[TBL] [Abstract][Full Text] [Related]
18. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells.
Tinsley JH; Wu MH; Ma W; Taulman AC; Yuan SY
J Biol Chem; 1999 Aug; 274(35):24930-4. PubMed ID: 10455168
[TBL] [Abstract][Full Text] [Related]
19. Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: towards a candidate biomarker.
Vilgrain I; Sidibé A; Polena H; Cand F; Mannic T; Arboleas M; Boccard S; Baudet A; Gulino-Debrac D; Bouillet L; Quesada JL; Mendoza C; Lebas JF; Pelletier L; Berger F
PLoS One; 2013; 8(12):e80056. PubMed ID: 24358106
[TBL] [Abstract][Full Text] [Related]
20. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts.
Nawroth R; Poell G; Ranft A; Kloep S; Samulowitz U; Fachinger G; Golding M; Shima DT; Deutsch U; Vestweber D
EMBO J; 2002 Sep; 21(18):4885-95. PubMed ID: 12234928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
